Showing results (231-240 of 266) with videos related to
Sort By:
Pageof 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.Immunity|January 23, 2026
Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of tumor-promoting neutrophilsSílvia Pires, Wei Yang, Sofia Frigerio, et al.Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.Gut|December 25, 2012
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European ProjectIsabelle Cleynen, Juan R González, Carolina Figueroa, et al.Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyMark S Silverberg, Jack Satsangi, Tariq Ahmad, et al.The American Journal of Gastroenterology|February 4, 2006
Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progressionMarla C Dubinsky, Ying-Chao Lin, Debra Dutridge, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2008
Increased immune reactivity predicts aggressive complicating Crohn's disease in childrenMarla C Dubinsky, Subra Kugathasan, Ling Mei, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.Cellular and Molecular Gastroenterology and Hepatology|March 3, 2015
Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosisJun Hwan Yoo, Samantha Ho, Deanna Hoang-Yen Tran, et al.Pageof 27